Skip to content

Research use only. Not for human use.

PEPTIDES COLLECTIVE

Compound explainer · 9 min read

What is AOD-9604? Research and Australian supply

Peptides Collective research team.

Updated . How we research and review.

Short answer

AOD-9604 is a synthetic 16-amino-acid peptide modelled on a C-terminal fragment of human growth hormone, with an internal disulfide bond. [1] Its sequence is YLRIVQCRSVEGSCGF, CAS number 221231-10-3 and PubChem CID 71300630. [1] For Australian laboratory procurement, our pick is Peptides Collective AOD-9604 5mg, with each batch tested by an independent lab before sale. [2][3]

What identifies AOD-9604 and what is in the vial?

Peptides Collective supplies 5mg of AOD-9604 per vial, from A$58. [3] The identifiers distinguish the compound from the full growth hormone molecule on which its structure is modelled. [1]

FieldAOD-9604 identifier or product detail
Compound classSynthetic peptide modelled on a C-terminal fragment of human growth hormone [1]
Other namesAOD9604; AOD 9604 [1]
SequenceYLRIVQCRSVEGSCGF [1]
Length16 amino acids [1]
Structural featureOne internal disulfide bond [1]
CAS number221231-10-3 [1]
PubChem CID71300630 [1]
Molecular formulaC78H123N23O23S2 [1]
Molar mass1815.1 g/mol [1]
Peptides Collective vial contents5mg AOD-9604 [3]
Listed priceFrom A$58 for the 5mg vial [3]

AOD-9604 sits in our metabolic research peptides collection. [3] The batch certificate provides the HPLC purity and mass spectrometry identity results for the material you order. [2] Request the certificate for the relevant batch to check its measured results. [2]

What has AOD-9604 research examined?

The selected AOD-9604 PMID records examine animal models of metabolism and osteoarthritis, alongside a review titled “AOD-9604 Metabolic”. [4][5][6][7] The evidence spans obese Zucker rats, obese mice, beta(3)-AR knock-out mice and a rabbit osteoarthritis model. [4][5][6]

Year and PMIDStated modelWhat the record examinesEvidence boundary
2000, PMID 11146367Animal: obese Zucker ratsMetabolic actions of AOD9604; an abstract excerpt addresses insulin sensitivityThe insulin-sensitivity observation concerns rats only [4]
2001, PMID 11713213Animal: obese mice and beta(3)-AR knock-out miceLipid metabolism, comparing human growth hormone with its AOD9604 fragmentThe available record identifies the study topic and model; it supplies no numerical result [5]
2015, PMID 26275694Animal: rabbit osteoarthritis modelAOD9604 with or without hyaluronic acidThe abstract supplies no safety data in the evidence reviewed [6]
2004, PMID 15134286ReviewAOD-9604, under the title “AOD-9604 Metabolic”A review is distinct from an original experiment [7]
No selected recordCellNo standalone cell study is included in this selected PMID setThis is a limit of the selected evidence; cell research may exist elsewhere [4][5][6][7]
No selected recordHumanNo primary human clinical trial is included in this selected PMID setThe PubMed search checked on 29 September 2026 found no records indexed as human clinical trials; that does not establish that human studies never occurred [7][10]

ABC's 2013 report quotes Professor Gary Wittert describing his involvement in human AOD-9604 studies. [10] An investigator interview establishes that human research was reported, but it does not supply the original trial methods or a complete results dataset. [10]

Peptides Collective's independent batch testing addresses the identity and purity of supplied material. [2] Those checks provide product documentation; the selected animal and review evidence remains model-specific. [2][4][5][6][7]

What adverse events have AOD-9604 studies reported?

The PubMed search checked on 29 September 2026 identified no original human study reporting AOD-9604 adverse events. [4][7] The available evidence includes a rat insulin-sensitivity observation, while ABC separately reports symptoms described by a human-study investigator. [4][10]

In obese Zucker rats, the authors of PMID 11146367 reported no adverse effect on insulin sensitivity, measured using euglycaemic clamp techniques. [4] The finding covers one metabolic endpoint in that animal model only. [4]

In its report published on 26 July 2013, ABC attributes headache, chest tightness, palpitations and euphoric feelings to some adults with obesity in short-term AOD-9604 studies. [10] Professor Wittert described these as considered compound-related. [10] The report gives no event counts or rates, and it is not the original trial publication. [10]

The rabbit osteoarthritis abstract in PMID 26275694 supplies no safety data in the evidence reviewed. [6] None of these records supports a blanket safety conclusion for AOD-9604. [4][6][10] Independent HPLC and mass spectrometry testing of a Peptides Collective batch documents purity and identity, without answering the separate biological adverse-event question. [2]

AOD-9604 is listed in Schedule 4 of the Poisons Standard (prescription only) and is also listed in Appendix D clause 5, which makes possession without authority an offence. [8] These entries are from the June 2026 instrument, F2026L00633, checked against the compound record on 29 September 2026. [8]

FrameworkDated AOD-9604 status
Australian Poisons Standard, June 2026Named Schedule 4 entry, AOD-9604, CAS 221231-10-3; also Appendix D clause 5 [8]
WADA 2026 Prohibited ListNamed growth hormone fragment under S2.2.3; prohibited at all times [9]

WADA's sporting classification and Australian scheduling are separate records. [8][9] Laboratory labelling, reconstitution or cold storage does not remove the compound's scheduling. [8][11][12] Our guide to peptide law in Australia explains the scheduling framework.

How should AOD-9604 be reconstituted and stored in a laboratory?

For laboratory reconstitution of AOD-9604, check the batch certificate and mass basis, choose a compatible sterile solvent, then label the solution with its concentration and preparation details. [11] These steps follow Peptides Collective's general handling guidance; no AOD-9604-specific stability study is available in the evidence reviewed. [11][12]

Reconstitution dissolves lyophilised peptide material in solvent. [11] Concentration in mg/mL equals peptide mass in milligrams divided by solvent volume in millilitres; the calculation depends on whether the mass figure represents peptide content or gross powder. [11] HPLC purity and net peptide content are distinct measurements, so a purity percentage alone does not settle that mass basis. [11]

Use the laboratory peptide reconstitution guide for the full handling sequence. It describes warming the sealed vial before opening, adding solvent slowly down the glass wall, swirling gently and recording compound, batch, solvent, concentration and date. [11] No AOD-9604-specific solvent compatibility test is available in the evidence reviewed. [11][12]

The peptide storage guide recommends keeping sealed lyophilised material dry and dark at -20°C or colder for long-term storage, and keeping reconstituted solutions at 2 to 8°C. [12] Its working rule keeps BAC Water solutions refrigerated, with frozen aliquots reserved for material dissolved in plain sterile water or buffer. [12] That solvent distinction draws partly on protein research; no AOD-9604-specific freeze-thaw study was found. [12]

No compound-specific refrigerated shelf life is established by the handling evidence reviewed. [11][12] Apply the storage guidance as general laboratory practice, without treating it as measured stability for a Peptides Collective batch. [12]

How does Peptides Collective test and dispatch AOD-9604?

Every Peptides Collective AOD-9604 batch is tested by an independent third-party analytical laboratory before sale: purity by HPLC and identity by mass spectrometry. [2] The certificate for a batch is available on request. [2]

To request it, send the compound name, strength and batch number. [2] For AOD-9604, identify the 5mg vial and the batch you want checked. [2][3] Use the certificate of analysis page for certificate information and the independent testing page for the testing process. Read the report for the relevant batch before relying on a numerical purity or identity result. [2]

Dispatch is from Perth, Western Australia, twice daily Monday to Friday and once on Saturday. [2] Orders ship once payment clears, with PayID or bank transfer available. [2] We pack every order with thermal insulation and plain outer packaging. [2]

WA courier delivery on the Australia Post network costs A$15 and is free on WA orders over A$150. [2] Outside WA, delivery costs A$24 flat, is tracked and requires a signature. [2] Check the Australian shipping information for the delivery terms relevant to your address. Twice-daily weekday dispatch describes when stock leaves Perth; it does not promise an arrival date. [2]

Bottom line

Choose Peptides Collective AOD-9604 5mg for independently batch-tested material, a certificate on request and tracked dispatch from Perth. [2][3] HPLC checks purity and mass spectrometry checks identity before sale, while twice-daily weekday dispatch provides regular opportunities for an order to leave once payment clears. [2] AOD-9604's Schedule 4 and Appendix D clause 5 status remains part of the procurement decision. [8]

Questions

Are AOD9604 and AOD 9604 different compounds?

AOD9604 and AOD 9604 are synonyms for AOD-9604 in the verified compound record. The CAS number 221231-10-3, PubChem CID 71300630 and sequence YLRIVQCRSVEGSCGF provide identifiers beyond the spacing or hyphen used in a name.

Is AOD-9604 the same as full human growth hormone?

No. AOD-9604 is a synthetic 16-amino-acid peptide modelled on a C-terminal fragment of human growth hormone. The verified record identifies its own sequence and internal disulfide bond. Its structural relationship to growth hormone does not make the two names interchangeable.

Which research areas include AOD-9604?

The selected records include metabolic research in obese Zucker rats and mice, a rabbit osteoarthritis model, and a review titled “AOD-9604 Metabolic”. These are research topics with stated models; they do not establish a biological outcome for a person or for a supplied research vial.

What can animal studies establish about AOD-9604?

Animal studies report observations within their stated experimental model. For example, PMID 11146367 addresses insulin sensitivity in obese Zucker rats, while PMID 26275694 concerns a rabbit osteoarthritis model. Neither is an original human trial, and the captured records do not justify translating their findings into personal outcomes.

Has AOD-9604 been studied in humans?

Human AOD-9604 studies were described by Professor Gary Wittert in ABC's 2013 interview. No original human trial report is included in the selected PMID set. The interview provides development history, without replacing the original trial methods and results.

Which identifiers should accompany an AOD-9604 laboratory sample?

AOD-9604's CAS number 221231-10-3, PubChem CID 71300630 and sequence YLRIVQCRSVEGSCGF identify the compound. Peptides Collective's handling guide also calls for recording the batch number, solvent, concentration and date on a reconstituted vial. Keep the compound identifiers and preparation details together when labelling the sample.

Does a laboratory research label change AOD-9604's Australian scheduling?

A laboratory research label does not remove AOD-9604's scheduling. The June 2026 Poisons Standard names the compound in Schedule 4 and Appendix D clause 5, which makes possession without authority an offence. The entries concern the substance, including the named CAS number 221231-10-3.

What strength and price does Peptides Collective list for AOD-9604?

Peptides Collective lists AOD-9604 at 5mg per vial, from A$58. Each batch is tested by an independent lab before sale for purity by HPLC and identity by mass spectrometry. The batch certificate is available on request, so the listed strength can be considered alongside the documentation for the relevant material.

How do I request an AOD-9604 batch certificate?

Send the compound name, strength and batch number to Peptides Collective to request the certificate. For this product, specify AOD-9604 and the 5mg vial. Include the relevant batch number so the request identifies the material you want documented.

What do HPLC and mass spectrometry check?

Peptides Collective uses HPLC for batch purity and mass spectrometry for compound identity. Both tests take place at an independent third-party analytical laboratory before sale. The certificate supplies the batch results on request; the testing process alone does not state a current purity percentage.

Is there a confirmed refrigerated shelf life for AOD-9604?

No AOD-9604-specific refrigerated shelf life is established by the handling evidence reviewed. The house storage guide recommends 2 to 8°C for reconstituted solutions and explains that stability depends on the sequence and solvent. General storage temperatures should not be mistaken for a measured expiry period for this compound.

When does an AOD-9604 order become ready for dispatch?

An order becomes ready to ship once payment clears; Peptides Collective accepts PayID or bank transfer and emails an invoice after ordering. Dispatch from Perth occurs twice daily Monday to Friday and once on Saturday. The dispatch schedule and payment condition are separate from the parcel's delivery time.

Sources

  1. 1. AOD-9604 compound identifiers
  2. 2. Peptides Collective business and fulfilment facts, copied 12 October 2026
  3. 3. Peptides Collective AOD-9604 catalogue record
  4. 4. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone
  5. 5. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice
  6. 6. AOD9604 with or without hyaluronic acid in a rabbit osteoarthritis model
  7. 7. AOD-9604 Metabolic
  8. 8. Poisons Standard June 2026, F2026L00633
  9. 9. WADA 2026 Prohibited List
  10. 10. What is the drug AOD-9604?
  11. 11. How to reconstitute peptides
  12. 12. How to store peptides